Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.3750
-0.0120 (-3.10%)
Aug 1, 2025, 3:44 PM AEST
Recce Pharmaceuticals Revenue
Recce Pharmaceuticals had revenue of 6.95M AUD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 9.59M, up 42.20% year-over-year. In the fiscal year ending June 30, 2024, Recce Pharmaceuticals had annual revenue of 5.03M with 15.19% growth.
Revenue (ttm)
9.59M
Revenue Growth
+42.20%
P/S Ratio
11.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
108.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 5.03M | 663.14K | 15.19% |
| Jun 30, 2023 | 4.37M | 1.28M | 41.50% |
| Jun 30, 2022 | 3.08M | 1.45M | 88.41% |
| Jun 30, 2021 | 1.64M | 515.66K | 45.97% |
| Jun 30, 2020 | 1.12M | 442.10K | 65.05% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Recce Pharmaceuticals News
- 15 days ago - Security breach laid bare as gangster shot dead inside city hosp; police suspect recce - The Times of India
- 1 year ago - Delhi Police foil terror designs on Independence Day with arrest of 'IS man' - The Times of India